Amplexor in PharmaTimes

Linguistic validation of routine clinical outcome assessments (COAs) – most notably patient reported outcomes and clinician reports – are proving an all-too-common stumbling block for clinical trial sponsors and contract research organisations (CROs). This goes beyond accurate translations of COA measures, to ensure that points of reference are culturally relevant for those making the assessments.